The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study
暂无分享,去创建一个
Ohoud Aljuhani | H. Alkofide | Shmeylan A Al Harbi | H. Badreldin | B. Alanazi | G. Korayem | Khalid Al Sulaiman | Abdulrahman I. Al Shaya | Abdullah Kharbosh | Raed Kensara | R. Vishwakarma | H. Al-Dorzi | A. Altebainawi | A. F. Alharthi | Jahad Alghamdi | Ahad Alawad | R. Alotaibi | Abdulmohsen Alhuwahmel | Mohammed Almusallam | B. Al-Dosari | Alawi S. Alsaeedi | Hessa Al Muqati | Ghada Albarrak | Ibrahim Al Sulaihim | Ghassan Al Ghamdi | A. Alharthi | Khalid A. Al Sulaiman | Shmeylan A. Al Harbi